Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics
New products on world’s medical product marketplace:

Industry News

Image: Research shows the global volume of IVD procedures, excluding certain segments of the industry, reached 21.4 billion in 2016 (Photo courtesy of iStock).

Global Volume of IVD Procedures Exceeds 21 Billion in 2016

The global volume of in vitro diagnostic (IVD) procedures, excluding the over-the counter (OTC) point of care (POC) market and professional POC glucose monitoring activity, reached 21.4 billion in 2016. Currently, an estimated 80% of all conditions diagnosed by physicians worldwide are based at least partially on the results of IVD procedures. More...
18 Apr 2017
Image: The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025 (Photo courtesy of Medgadget).

Global Analyzer Market to Reach USD 16.0 Billion by 2025

The global market for clinical chemistry analyzers is expected to reach USD 16.0 billion by 2025, driven by their increased adoption due to the growing prevalence of chronic diseases, fueled further by an increasing geriatric and bariatric population, which is highly susceptible to chronic diseases. The resulting high sample volume requiring high capability analyzing devices will drive the growth of the global clinical chemistry analyzers market, going forward. More...
31 Mar 2017
Image: Streck has entered into a distribution agreement with Dow Biomedica for its cell stabilization, molecular and flow cytometry products (Photo courtesy of iStock).

Streck Enters Distribution Agreement with Dow Biomedica

Streck, Inc., which develops and manufactures products for clinical and research laboratories, has entered into a distribution agreement for its cell stabilization, molecular and flow cytometry products with Dow Biomedica, a distributor of diagnostic products specializing in immunology, microbiology and QC materials. More...
31 Mar 2017
Image: Greiner Bio-One will serve customers in Spain and Portugal through its own distribution subsidiaries (Photo courtesy of iStock).

Greiner Bio-One to Serve Spain and Portugal through Distribution Subsidiaries

Greiner Bio-One has acquired its long-standing distribution partners, VacuetteEspaña and Vacuette Portugal, which will now allow the medical technology company to serve its customers in Spain and Portugal directly through its own distribution subsidiaries. More...
28 Mar 2017
Image: Increased sales in the point-of-care testing market have been attributed to new technology available in medical devices designed for clinical and home use (Photo courtesy of iStock).

POCT Market Reaches USD 18 Billion in 2016

Sales of point of care (POC) diagnostic testing, both professional testing and self-testing, reached USD 18.4 billion in 2016, driven by emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices that aim to provide expedited diagnosis where the patient is seen or in the patient’s home. These new technologies are allowing POC devices to generate quantitative lab-quality test results and transfer them automatically to an information system, a remote caregiver service for consultation or an electronic medical record. More...
10 Mar 2017
Image: The Binding Site and the Mayo Clinic have agreed to collaborate on the development of a test that will better diagnose and monitor B-cell diseases (Photo courtesy of iStock).

Collaboration Improves Diagnosis and Monitoring of Multiple Myeloma

The Binding Site Group Ltd. has entered into a collaboration agreement with Mayo Clinic to develop a clinical laboratory test for the identification and accurate measurement of monoclonal proteins present in B-cell diseases. Both the organizations have been involved in collaborative activities for more than two decades with the aim of improving the testing, diagnosis and monitoring of patients with multiple myeloma and related conditions. The output of the latest collaboration will build on combining The Binding Site’s antibody- and assay-development expertise with Mayo Clinic’s clinical excellence and its recently patented approach to improving multiple myeloma patient monitoring. More...
10 Mar 2017
Image: The growing molecular diagnostics market is worth of almost USD 7 billion, according to recent findings (Photo courtesy of iStock).

Molecular Diagnostics Market Worth Nearly USD 7 Billion

The size of the molecular diagnostic testing market has reached USD 6.7 billion and is being driven by the growing threat of infectious disease and cancer, as well as the development of new products. These are the latest findings of Kalorama Information, an independent medical market research firm. More...
21 Feb 2017


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
Copyright © 2000-2017 Globetech Media. All rights reserved.